• Startseite
• generic
• Company Moves: The Latest in the Global Generics Market - DCAT Value Chain Insights

Company Moves: The Latest in the Global Generics Market - DCAT Value Chain Insights

4.6 (157) · € 22.99 · Auf Lager

Novartis’ decision to spin out Sandoz, its generics and biosimilars business, into a separate, stand-alone company is the latest move in the highly cost-competitive generics market. What was behind Novartis’ decision, and how does it fit with other recent deals?

A Top 10 Emerging Pharma Watch List - DCAT Value Chain Insights

Global API Market: Crunching the Numbers - DCAT Value Chain Insights

Sustainability, Free Full-Text

Construction Equipment Market Size & Share Report, 2030

2024 banking industry outlook

Pharma Supply Chain People Moves

Controlant Company Insight - Pharma Technology Focus, Issue 106

Caterpillar flags supply-chain risks as global recovery boosts earnings

Pharma Company on the Move: The New AbbVie - DCAT Value Chain Insights